Dr. Medishetti Swetha

Department of Pharmaceutical Regulatory Affairs            

 swethasnvpm@gmail.com      

RESEARCH INTEREST:

 Phytoconstituents, bioactive compounds extracted from plants, are being utilized in novel formulations across various industries.

Regulatory compliance of medical foods & neutraceuticals .

EDUCATIONAL DETAILS:

• Awarded PhD in 2023 from JNTUH for the title “Chrono Therapeutic Drug Delivery System for Selected Drugs”
• PG Diploma in IPR from Osmania University. 2013
• Completed M.Pharmacy from Sri Venkateswara University in 2008-2010 with 76.8%.
• Pharmacy in Si Padmavathi Mahila Viswa Vidyalam ,Tirupathi with 70%

CAREER ACHIVEMENTS:

• Working as one of the faculty coordinator for UBA.
• Won “Late Smt. Shyam Sundri Memorial Young Women Researcher Award 2023” from APP.
• Granted a UK Design Patent for “High Speed Multi-axis Driven Injectable Dry Powder Filling Machine” in 2023.
• Published 45 research papers with 697 citations and an h-index of 2.
• Projects guided (PG &UG) – 12.
• Authored a book chapter Introduction to Nutrition and Autoimmune Diseases” in “Nutrition Controversies and Advances in Autoimmune Disease”
• book Chapter12: The Microbiota–Gut–Brain Axis in Neurodegeneration: Molecular Mechanisms, Disease-Specific Insights, and Therapeutic Opportunities in the Book name Autophagy and Cell Death Pathways in Neurodegeneration: Crosstalk, Mechanisms, and Therapeutic Strategies by Bentham Sciences .
   Accepted the Book Chapter 09: Multi-Target Drug Discovery Strategies for the Parkinson’s disease in the book name Systems Biology and Network Pharmacology in Neurodegeneration: Multi-Target Approaches by Bentham Sciences.
   Authored a book chapter titled “Introduction to Nutrition and Autoimmune Diseases.” Scopus indexed with ISBN12 DOI: 10.4018/979-8-3693-5528-2.ch001.
   Secured a UK Design Patent (No. 6289592, 9-8-2023) for a “High Speed Multi-axis Driven Injectable Dry powder Filling Machine” (International Design Classification).
  Indian Patent Application No. 202641001937 and titled “Antiepileptic Activity of Nigella Sativa: A Phytochemical and Pharmacological Evaluation,” was published by the Indian Patent Office on January 30, 2026. The filing explores the chemical composition and therapeutic potential of the plant in managing seizure disorders.
• Organized a seminar “Orientation on UBA and Mission LIFE Programme” 20-01-2024
• Organized an event on world diabetes day -2022 as Program coordinator in SNVPMV.